Morphogens and hepatic stellate cell fate regulation in chronic liver disease

Journal of Gastroenterology and Hepatology (Australia)

Volumn 27, Issue SUPPL.2, 2012, Pages 94-98

  Tsukamoto, Hidekazu ^a,b   Zhu, Nian Ling ^a   Wang, Jiaohong ^a   Asahina, Kinji ^a   Machida, Keigo ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

Author keywords

Necdin; Ppar ; Shh; Wnt

Indexed keywords

BETA CATENIN; COLLAGEN; COLLAGEN TYPE 1; COLLAGEN TYPE 4; DICKKOPF 1 PROTEIN; GAMMA SECRETASE; LEPTIN; MATRIX METALLOPROTEINASE INHIBITOR; METALLOPROTEINASE INHIBITOR; MONOCYTE CHEMOTACTIC PROTEIN 1; MORPHOGEN; NECDIN; NOTCH RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PLATELET DERIVED GROWTH FACTOR; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE DEHYDROGENASE; SONIC HEDGEHOG PROTEIN; TOLL LIKE RECEPTOR; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; WNT PROTEIN;

ADIPOCYTE; ARTICLE; CARCINOGENESIS; CELL DIFFERENTIATION; CELL FATE; CHRONIC LIVER DISEASE; FIBROBLAST; HUMAN; LIVER REGENERATION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SIGNAL TRANSDUCTION; STELLATE CELL;

EID: 84863023178     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2011.07022.x     Document Type: Article

References (46)

1. Yamada M, Blaner WS, Soprano DR, Dixon JL, Kjeldbye HM, Goodman DS. Biochemical characteristics of isolated rat liver stellate cells. Hepatology 1987; 7: 1224-9.
2. Kano K etal. Uber den EingluB der Insulin-Traubenzucker-Injektion auf die "Fettspeicherungsellen" der Leber. Arch. Histol. Jpn. 1952; 4: 13-24.
3. Sunaga Y. Uber den EinfluB der Insulin-Traubenzucker-Injektion auf die "Fettspeicherungsellen" der Leber. Arch. Histol. Jpn. 1954; 7: 241-9.
4. Ito T etal. Studies on the "fat-storing cells" (Fettspeicherungszellen) in the liver. Arch. Anat. Nippon. 1956; 31: 10-15.
5. Friedman SL. Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol. Rev. 2008; 88: 125-72.
6. Cassiman D, Barlow A, Vander BS, Libbrecht L, Pachnis V. Hepatic stellate cells do not derive from the neural crest. J. Hepatol. 2006; 44: 1098-104.
7. Geerts A. History, heterogeneity, developmental biology, and functions of quiescent hepatic stellate cells. Semin. Liver Dis. 2001; 21: 311-35.
8. Asahina K, Tsai SY, Li P etal. Mesenchymal origin of hepatic stellate cells, submesothelial cells, and perivascular mesenchymal cells during mouse liver development. Hepatology 2009; 49: 998-1011.
9. Asahina K, Zhou B, Pu WT, Tsukamoto H. Septum transversum-derived mesothelium gives rise to hepatic stellate cells and perivascular mesenchymal cells in developing mouse liver. Hepatology 2011; 53: 983-95.
10. Potter JJ, Womack L, Mezey E, Anania FA. Transdifferentiation of rat hepatic stellate cells results in leptin expression. Biochem. Biophys. Res. Commun. 1998; 244: 178-82.
11. Potter JJ, Mezey E. Acetaldehyde increases endogenous adiponectin and fibrogenesis in hepatic stellate cells but exogenous adiponectin inhibits fibrogenesis. Alcohol. Clin. Exp. Res. 2007; 31: 2092-100.
12. She H, Xiong S, Hazra S, Tsukamoto H. Adipogenic transcriptional regulation of hepatic stellate cells. J. Biol. Chem. 2005; 280: 4959-67.
13. Miyahara T, Schrum L, Rippe R etal. Peroxisome proliferator-activated receptors and hepatic stellate cell activation. J. Biol. Chem. 2000; 275: 35715-22.
14. Spiegelman BM, Flier JS. Adipogenesis and obesity: rounding out the big picture. Cell 1996; 87: 377-89.
15. Hazra S, Xiong S, Wang J etal. Peroxisome proliferator-activated receptor gamma induces a phenotypic switch from activated to quiescent hepatic stellate cells. J. Biol. Chem. 2004; 279: 11392-401.
16. Yavrom S, Chen L, Xiong S, Wang J, Rippe RA, Tsukamoto H. Peroxisome proliferator-activated receptor gamma suppresses proximal alpha1(I) collagen promoter via inhibition of p300-facilitated NF-I binding to DNA in hepatic stellate cells. J. Biol. Chem. 2005; 280: 40650-9.
17. Marra F, Efsen E, Romanelli RG etal. Ligands of peroxisome proliferator-activated receptor gamma modulate profibrogenic and proinflammatory actions in hepatic stellate cells. Gastroenterology 2000; 119: 466-78.
18. Galli A, Crabb DW, Ceni E etal. Antidiabetic thiazolidinediones inhibit collagen synthesis and hepatic stellate cell activation in vivo and in vitro. Gastroenterology 2002; 122: 1924-40.
19. Le NH, Franken P, Fodde R. Tumour-stroma interactions in colorectal cancer: converging on β-catenin activation and cancer stemness. Br. J. Cancer 2008; 98: 1886-93.
20. Lehwald N, Tao G-Z, Jang KY, Sorkin M, Knoefel WT, Sylvester KG. Wnt-β-catenin signaling protects against hepatic ischemia and reperfusion injury in mice. Gastroenterology 2011; 141: 707-18.
21. Bennett CN, Ross SE, Longo KA etal. Regulation of Wnt signaling during adipogenesis. J. Biol. Chem. 2002; 277: 30998-1004.
22. Ross SE, Hemati N, Longo KA etal. Inhibition of adipogenesis by Wnt signaling. Science 2000; 289: 950-3.
23. Cheng JH, She H, Han YP etal. Wnt antagonism inhibits hepatic stellate cell activation and liver fibrosis. Am. J. Physiol. Gastrointest. Liver Physiol. 2008; 294: G39-49.
24. Tseng YH, Butte AJ, Kokkotou E etal. Prediction of preadipocyte differentiation by gene expression reveals role of insulin receptor substrates and necdin. Nat. Cell Biol. 2005; 7: 601-11.
25. Kuwajima T, Nishimura I, Yoshikawa K. Necdin promotes GABAergic neuron differentiation in cooperation with Dlx homeodomain proteins. J. Neurosci. 2006; 26: 5383-92.
26. Kuwajima T, Taniura H, Nishimura I, Yoshikawa K. Necdin interacts with the Msx2 homeodomain protein via MAGE-D1 to promote myogenic differentiation of C2C12 cells. J. Biol. Chem. 2004; 279: 40484-93.
27. Brunelli S, Tagliafico E, De Angelis FG etal. Msx2 and necdin combined activities are required for smooth muscle differentiation in mesoangioblast stem cells. Circ. Res. 2004; 94: 1571-8.
28. Zhu NL, Wang J, Tsukamoto H. The necdin-Wnt pathway causes epigenetic peroxisome proliferator-activated receptor gamma repression in hepatic stellate cells. J. Biol. Chem. 2010; 285: 30463-71.
29. Mann J, Chu DC, Maxwell A etal. MeCP2 controls an epigenetic pathway that promotes myofibroblast transdifferentiation and fibrosis. Gastroenterology 2010; 138: 705-14.
30. Szulwach KE, Li X, Smrt RD etal. Cross talk between microRNA and epigenetic regulation in adult neurogenesis. J. Cell Biol. 2010; 189: 127-41.
31. Yang L, Wang Y, Mao H etal. Sonic hedgehog is an autocrine viability factor for myofibroblastic hepatic stellate cells. J. Hepatol. 2008; 48: 98-106.
32. Lin N, Tang Z, Deng M etal. Hedgehog-mediated paracrine interaction between hepatic stellate cells and marrow-derived mesenchymal stem cells. Biochem. Biophys. Res. Commun. 2008; 372: 260-5.
33. Jung Y, Diehl AM. Non-alcoholic steatohepatitis pathogenesis: role of repair in regulating the disease progression. Dig. Dis. 2010; 28: 225-8.
34. Oakley F, Mann J, Ruddell RG, Pickford J, Weinmaster G, Mann DA. Basal expression of IkappaBalpha is controlled by the mammalian transcriptional repressor RBP-J (CBF1) and its activator Notch1. J. Biol. Chem. 2003; 278: 24359-70.
35. Sawitza I, Kordes C, Reister S, Haussinger D. The niche of stellate cells within rat liver. Hepatology 2009; 50: 1617-24.
36. Monga SP, Pediaditakis P, Mule K, Stolz DB, Michalopoulos GK. Changes in WNT/beta-catenin pathway during regulated growth in rat liver regeneration. Hepatology 2001; 33: 1098-109.
37. Ochoa B, Syn WK, Delgado I etal. Hedgehog signaling is critical for normal liver regeneration after partial hepatectomy in mice. Hepatology 2010; 51: 1712-23.
38. Apte U, Zeng G, Muller P etal. Activation of Wnt/beta-catenin pathway during hepatocyte growth factor-induced hepatomegaly in mice. Hepatology 2006; 44: 992-1002.
39. Lin A, Frost J, Deng T etal. Casein kinase II is a negative regulator of c-Jun DNA binding and AP-1 activity. Cell 1992; 70: 777-89.
40. Channavajhala P, Seldin DC. Functional interaction of protein kinase CK2 and c-Myc in lymphomagenesis. Oncogene 2002; 21: 5280-8.
41. Pando MP, Verma IM. Signal-dependent and -independent degradation of free and NF-kappa B-bound IkappaBalpha. J. Biol. Chem. 2000; 275: 21278-86.
42. Song DH, Dominguez I, Mizuno J, Kaut M, Mohr SC, Seldin DC. CK2 phosphorylation of the armadillo repeat region of beta-catenin potentiates Wnt signaling. J. Biol. Chem. 2003; 278: 24018-25.
43. Ponce DP, Maturana JL, Cabello P etal. Phosphorylation of AKT/PKB by CK2 is necessary for the AKT-dependent up-regulation of beta-catenin transcriptional activity. J. Cell. Physiol. 2011; 226: 1953-9.
44. de La CA, Romagnolo B, Billuart P etal. Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas. Proc. Natl. Acad. Sci. U.S.A. 1998; 95: 8847-51.
45. Devereux TR, Anna CH, Foley JF, White CM, Sills RC, Barrett JC. Mutation of beta-catenin is an early event in chemically induced mouse hepatocellular carcinogenesis. Oncogene 1999; 18: 4726-33.
46. Yanai H, Nakamura K, Hijioka S etal. Dlk-1, a cell surface antigen on foetal hepatic stem/progenitor cells, is expressed in hepatocellular, colon, pancreas and breast carcinomas at a high frequency. J. Biochem. 2010; 148: 85-92.